HIEFF
LIVE

Serial Number

79453244

Owner

Yeasen Biotechnology (Shanghai) Co., Ltd

Filing Date

May 9, 2026

Add to watchlist:

No watchlists yet
View on USPTO

HIEFF Trademark

Serial Number: 79453244

HIEFF is a trademark filed by Yeasen Biotechnology (Shanghai) Co., Ltd on May 9, 2026. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Yeasen Biotechnology (Shanghai) Co., Ltd (2 trademarks)

Building 1, Room 402, 166 Tianxiong Road,

Entity Type: 99

Trademark Details

Filing Date

May 9, 2026

Registration Date

Not Registered

Goods & Services

Diagnostic biomarker reagents for medical purposes; medicines for human purposes; antiseptics; biological tissue cultures for medical purposes; vaccines; biological preparations for medical purposes; chemico-pharmaceutical preparations; preparations of microorganisms for medical or veterinary use; enzyme preparations for medical purposes; bouillons for bacteriological cultures for medical purposes or veterinary purposes.

Enzymes for industrial purposes; enzyme preparations for industrial purposes; biological preparations, other than for medical or veterinary purposes; chemical reagents, other than for medical or veterinary purposes; preparations of microorganisms, other than for medical and veterinary use; biochemical catalysts; bacterial preparations, other than for medical and veterinary use; antioxidants for use in the manufacture of pharmaceuticals; chemical preparations for scientific purposes, other than for medical or veterinary use; chemical substances for analyses in laboratories, other than for medical or veterinary purposes.

Research and development of new products for others; quality testing; scientific research; scientific laboratory services; chemical research; chemical analysis; biological research; bacteriological research; material testing; calibration [measuring].

Filing History

SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 2, 2026 REPR